Inflammatory muscle diseases: Dermatomyositis, polymyositis, and inclusion body myositis;Entzündliche muskelkrankheiten: Polymyositis, dermatomyositis und einschlusskörpermyositis

Internist

Volumn 46, Issue 11, 2005, Pages 1218-1232

  Genth, E ^a,b  

^a Rheumaklinik und Rheumaforschungsinstitut Aachen ^*  (Germany)

^b Rheumaklinik und Rheumaforschungsinstitut   (Germany)

Author keywords

Dermatomyositis; Inclusion body myositis; Inflammatory muscle disease; Polymyositis

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CREATINE KINASE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE;

ANTISYNTHETASE SYNDROME; CANCER; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG MEGADOSE; DRUG SAFETY; DRUG USE; ENDOCRINE DISEASE; FREQUENCY ANALYSIS; HEART; HUMAN; IMMUNOPATHOLOGY; INCLUSION BODY MYOSITIS; INFECTION; JOINT; LUNG; METABOLIC DISORDER; MUSCLE BIOPSY; MUSCLE WEAKNESS; NEUROMUSCULAR DISEASE; OSTEOPOROSIS; POLYMYOSITIS; REVIEW; SKIN; SYSTEMIC DISEASE;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; DERMATOMYOSITIS; HUMANS; MYOSITIS; MYOSITIS, INCLUSION BODY; PHYSICIAN'S PRACTICE PATTERNS; POLYMYOSITIS; PRACTICE GUIDELINES; TREATMENT OUTCOME;

EID: 28744437789     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-005-1496-4     Document Type: Review

References (29)

1. Anders HJ, Wanders A, Rihl M, Kruger K (1999) Myocardial fibrosis in polymyositis. J Rheumatol 26: 1840-1842
2. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292: 344-347
3. Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC (1999) Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 42: 899-909
4. Christopher-Stine L, Plotz PH (2004) Myositis: an update on pathogenesis. Curr Opin Rheumatol 16: 700-706
5. Dalakas MC (2002) Muscle biopsy findings in inflammatory myopathies. Rheum Dis Clin North Am 28: 779-798
6. Dalakas MC (1998) Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis. Neurology 51 (Suppl): S37-45
7. Dalakas MC (2004) Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis. Curr Opin Neurol 17: 561-567
8. Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362: 971-982
9. De Vita S, Fossaluzza V (1992) Treatment of idiopathic inflammatory myopathies with cyclophosphamide pulses: clinical experience and a review of the literature. Acta Neurol Belg 92: 215-227
10. Fraser DD, Frank JA, Dalakas M, Miller FW, Hicks JE, Plotz P (1991) Magnetic resonance imaging in the idiopathic inflammatory myopathies. J Rheumatol 18: 1693-1700
11. Genth E (1998) Autoantikörper bei Dermato- und Polymyositiden. In: Conrad K (Hrsg) Autoantikörper. Pabst Science Publishers, Lengerich Berlin Düsseldorf Riga
12. Genth E, Kaufmann S, Mierau R (1993) Das Anti-(Aminoacyl-tRNA-) Synthetase-Syndrom (Jo-1-Syndrom). Ein eigenständiges Autoantikörper- assoziiertes Krankheitsbild mit Myositis, fibrosierender Alveolitis und Polyarthritis. Akt Rheumatol 7: 113-119
13. Hill CL, Zhang Y, Sigurgeirsson B et al. (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357: 96-100
14. Joffe MM, Love LA, Leff RL et al. (1993) Drug therapy of the idiopathic inflammatory myopathies: Predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. Am J Med 94: 379-387
15. Leff RL, Miller FW, Hicks J, Fraser DD, Plotz PH (1993) The treatment of inclusion body myositis: a retrospective review and a randomized, prospective trial of immunosuppressive therapy. Medicine (Baltimore) 72: 225-235
16. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70: 360-374
17. Mastaglia FL, Phillips BA (2002) Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin North Am 28: 723-741
18. Mastaglia FL, Zilko PJ (2003) Inflammatory myopathies: how to treat the difficult cases. J Clin Neurosci 10: 99-101
19. Mozaffar T, Pestronk A (2000) Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres. J Neurol Neurosurg Psychiatry 68: 472-478
20. Plotz PH, Rider LG, Targoff IN, Raben N, O'Hanlon TP, Miller FW (1995) NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 122: 715-724
21. Schnabel A, Reuter M, Biederer J, Richter C, Gross WL (2003) Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum 32: 273-284
22. Sigurgeirsson B, Lindelof B, Edhag O, Allander E (1992) Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326: 363-367
23. Sontheimer RD (2002) Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin 20: 387-408
24. Spiera R, Kagen L (1998) Extramuscular manifestations in idiopathic inflammatory myopathies. Curr Opin Rheumatol 10: 556-561
25. Sultan SM, Ioannou Y, Moss K, Isenberg DA (2002) Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford) 41: 22-26
26. Targoff IN (1992) Autoantibodies in polymyositis. Rheum Dis Clin North Am 18: 455-82
27. Targoff IN, Johnson AE, Miller FW (1990) Antibody to signal recognition particle in polymyositis Antibody to signal recognition particle in polymyositis. Arthritis Rheum 33: 1361-1370
28. Yamanishi Y, Maeda H, Katayama S, Ishioka S, Yamakido M (1996) Scleroderma-polymyositis overlap syndrome associated with anti-Ku antibody and rimmed vacuole formation. J Rheumatol 23: 1991-1994
29. Yazici Y, Kagen LJ (2002) Cardiac involvement in myositis. Curr Opin Rheumatol 14: 663-665